Chart of the day: Prostate cancer treatment “selfies”
Today’s chart comes from the recent GAO report on delivery of intensity-modulated radiation therapy (IMRT) for prostate cancer among Medicare patients by physician groups that do and
Today’s chart comes from the recent GAO report on delivery of intensity-modulated radiation therapy (IMRT) for prostate cancer among Medicare patients by physician groups that do and
True, Americans don’t understand some fundamentally important details of Obamacare very well. But it’s not just Obamacare. They don’t understand lots of fundamentally important details
The US has split over whether to implement the Medicaid expansion in the Affordable Care Act. The dark blue states are expanding Medicaid. Let’s imagine
Are you ready? Can you feel the excitement? I’d be lying if I didn’t say that I look forward to this post all year. It’s
Medicare now penalizes hospitals for high readmission rates for acute myocardial infarction (AMI), congestive heart failure (CHF), and pneumonia. Anticipating the penalties, readmission rates have come
During my internet-free week I did many other things including reading The Secrets of Happy Families, by Bruce Feiler. I chose it because it was one
I really liked Adrianna’s last column, “Read the fine print before you burn your Obamacare card.” We had a twitter exchange about it this morning
American politicians have debated the Affordable Care Act since it was introduced to Congress in 2009. Have these debates affected what citizens think about the
This is a guest post from Adrianna McIntyre, a graduate student studying health policy at the University of Michigan. Adrianna currently blogs at Project Millennial, tweets at @onceuponA,
Writing in the WSJ, Scott Gottlieb makes it sound like the Affordable Care Act has spawned a monster in the 340B drug pricing program (“How
The July 31 NYT Opinionator blog described in some detail pricing transparency at The Oklahoma Surgery Center. The NYT blog does not allege that Medicare prohibits pricing
It feel like all of you not only read this piece at the NYT on price transparency. I don’t think I’m as excited by it